Device Trial Radar · NCT04081246
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Sep 7, 2020
Primary completion
Mar 15, 2024
Study completion Mar 15, 2024
Sponsor
- Lead sponsor
- Chinese University of Hong KongAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 9, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Modified en bloc resection is a hybrid technique involving piecemeal resection of the exophytic part of the bladder tumour, followed by en bloc resection of the tumour base. In this study, we shall investigate the efficacy of modified en bloc resection for patients with bladder tumours of ≥3cm in size.
Conditions
- Bladder Cancer
- Bladder Neoplasm
- Bladder Tumor
Interventions
Bipolar transurethral modified en bloc resection of bladder tumourDevice
Olympus TURis Bipolar HF-resection electrode (Model: WA22306D)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite outcome on the rate of complete resection for non-muscle-invasive bladder cancer and proper staging for muscle-invasive bladder cancerTime frame: Seven weeks after the experimental operation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Prince of Wales Hospital
Hong Kong, Hong Kong
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.